These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37279375)

  • 1. Targeting Mycobacterium tuberculosis: Synthesis, in vitro and in silico evaluation of novel N
    Zawal AG; Abdel-Aziz MM; El-Shanawani AA; Abdel-Aziz LM; Taha M; Simons C; Elbaramawi SS
    Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300187. PubMed ID: 37279375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
    Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
    Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
    Nandikolla A; Mahadu Khetmalis Y; Mahalakshmi Naidu K; Karan Kumar B; Murugesan S; Chandra Sekhar KVG
    Toxicol In Vitro; 2022 Aug; 82():105370. PubMed ID: 35489549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis.
    Othman DIA; Hamdi A; Abdel-Aziz MM; Elfeky SM
    Bioorg Chem; 2022 Jul; 124():105809. PubMed ID: 35447406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV
    Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
    Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
    Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
    Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
    Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.
    Park B; Awasthi D; Chowdhury SR; Melief EH; Kumar K; Knudson SE; Slayden RA; Ojima I
    Bioorg Med Chem; 2014 May; 22(9):2602-12. PubMed ID: 24726304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
    Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
    Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives.
    Younis MH; Mohammed ER; Mohamed AR; Abdel-Aziz MM; Georgey HH; Abdel Gawad NM
    Bioorg Chem; 2022 Jul; 124():105807. PubMed ID: 35487073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.